These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 8769395

  • 1. The relevance of somatostatin receptor expression in malignant lymphomas.
    van den Anker-Lugtenburg PJ, Löwenberg B, Lamberts SW, Krenning EP.
    Metabolism; 1996 Aug; 45(8 Suppl 1):96-7. PubMed ID: 8769395
    [Abstract] [Full Text] [Related]

  • 2. Somatostatin receptor scintigraphy in the staging of lymphomas.
    Ivancević V, Wörmann B, Nauck C, Sandrock D, Munz DL, Hiddemann W, Emrich D.
    Leuk Lymphoma; 1997 Jun; 26(1-2):107-14. PubMed ID: 9250794
    [Abstract] [Full Text] [Related]

  • 3. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas.
    Lugtenburg PJ, Löwenberg B, Valkema R, Oei HY, Lamberts SW, Eijkemans MJ, van Putten WL, Krenning EP.
    J Nucl Med; 2001 Feb; 42(2):222-9. PubMed ID: 11216520
    [Abstract] [Full Text] [Related]

  • 4. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
    Lipp RW, Silly H, Ranner G, Dobnig H, Passath A, Leb G, Krejs GJ.
    J Nucl Med; 1995 Jan; 36(1):13-8. PubMed ID: 7799065
    [Abstract] [Full Text] [Related]

  • 5. Visualization of non-Hodgkin's lymphoma by high dosed somatostatin receptor specific scintigraphy and extended single photon emission tomography.
    Lipp RW, Schnedl WJ, Aglas F, Ranner G, Beham-Schmid C, Leb G, Sill H.
    Acta Med Austriaca; 1999 Jan; 26(3):105-8. PubMed ID: 10520379
    [Abstract] [Full Text] [Related]

  • 6. Indium-111 pentetreotide scintigraphy in malignant lymphomas.
    Sarda L, Duet M, Zini JM, Berolatti B, Benelhadj S, Tobelem G, Mundler O.
    Eur J Nucl Med; 1995 Oct; 22(10):1105-9. PubMed ID: 8542892
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
    Delcambre C, Reman O, Henry-Amar M, Peny AM, Macro M, Cheze S, Génot JY, Tanguy A, Switsers O, Van HL, Couëtte JE, Leporrier M, Bardet S.
    Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
    [Abstract] [Full Text] [Related]

  • 9. Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease.
    van den Anker-Lugtenburg PJ, Krenning EP, Oei HY, Van Hagen MP, Gerrits CJ, Reubi JC, Lamberts SW, Löwenberg B.
    Br J Haematol; 1996 Apr; 93(1):96-103. PubMed ID: 8611482
    [Abstract] [Full Text] [Related]

  • 10. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
    Apostolopoulos DJ, Papandrianos NI, Symeonidis A, Spyridonidis T, Alexiou S, Zampakis P, Savvopoulos C, Vassilakos PJ, Matsouka P.
    Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
    [Abstract] [Full Text] [Related]

  • 11. Somatostatin analogue scintigraphy of malignant lymphomas.
    Vanhagen PM, Krenning EP, Reubi JC, Mulder AH, Bakker WH, Oei HY, Löwenberg B, Lamberts SW.
    Br J Haematol; 1993 Jan; 83(1):75-9. PubMed ID: 8094627
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of carbon-11 methionine positron emission tomography to assess malignancy grade and predict survival in patients with lymphomas.
    Nuutinen J, Leskinen S, Lindholm P, Söderström KO, Någren K, Huhtala S, Minn H.
    Eur J Nucl Med; 1998 Jul; 25(7):729-35. PubMed ID: 9662595
    [Abstract] [Full Text] [Related]

  • 14. Initial staging of lymphoma with octreotide and other receptor imaging agents.
    Ferone D, Semino C, Boschetti M, Cascini GL, Minuto F, Lastoria S.
    Semin Nucl Med; 2005 Jul; 35(3):176-85. PubMed ID: 16098291
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P, Jiwa M, van der Valk P, Walboomers J, Horstman A, Meijer CJ.
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [Abstract] [Full Text] [Related]

  • 17. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY, Kao A, Yen RF.
    Oncol Rep; 2002 Jul; 9(2):321-5. PubMed ID: 11836600
    [Abstract] [Full Text] [Related]

  • 18. Tc-99m sestamibi imaging in the diagnostic assessment of patients with lymphomas: comparison with clinical and radiological evaluation.
    Maurea S, Acampa W, Varrella P, De Rosa V, Fimiani P, Abate G, Salvatore M.
    Clin Nucl Med; 1998 May; 23(5):283-90. PubMed ID: 9596152
    [Abstract] [Full Text] [Related]

  • 19. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type.
    Raderer M, Traub T, Formanek M, Virgolini I, Osterreicher C, Fiebiger W, Penz M, Jäger U, Pont J, Chott A, Kurtaran A.
    Br J Cancer; 2001 Nov 16; 85(10):1462-6. PubMed ID: 11720429
    [Abstract] [Full Text] [Related]

  • 20. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A, Berg R.
    Laryngoscope; 2001 Sep 16; 111(9):1565-9. PubMed ID: 11568605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.